Estatísticas para RT 1519 2019 - ANTI-VEGF (Avastin®, Eyla® ou Lucentis®) para Edema Macular Diabético - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| RT 1519 2019 - ANTI-VEGF (Avastin®, Eyla® ou Lucentis®) para Edema Macular Diabético - NATJUS TJMG | 4 |
Total visitas por mês
| views | |
|---|---|
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |
| April 2026 | 1 |
Visitas Arquivos
| views | |
|---|---|
| RT 1519.pdf | 20 |